Marzia Locatelli

1.6k total citations
36 papers, 1.2k citations indexed

About

Marzia Locatelli is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marzia Locatelli has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 15 papers in Cancer Research and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marzia Locatelli's work include Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Marzia Locatelli is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), HER2/EGFR in Cancer Research (10 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Marzia Locatelli collaborates with scholars based in Italy, United States and Belgium. Marzia Locatelli's co-authors include Giuseppe Curigliano, Carmen Criscitiello, Angela Espósito, Luca Fumagalli, Aron Goldhirsch, Ida Minchella, Lucia Gelao, Vincenzo Bagnardi, Nicole Rotmensz and Giuseppe Viale and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Pharmacology & Therapeutics.

In The Last Decade

Marzia Locatelli

34 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marzia Locatelli Italy 17 757 535 329 221 151 36 1.2k
Jiayi Wu China 20 853 1.1× 656 1.2× 281 0.9× 223 1.0× 139 0.9× 87 1.3k
Yoshiya Horimoto Japan 20 694 0.9× 378 0.7× 495 1.5× 235 1.1× 170 1.1× 97 1.2k
Weikai Xiao China 18 477 0.6× 473 0.9× 425 1.3× 265 1.2× 110 0.7× 37 1.1k
Maria Martinez‐García Spain 18 675 0.9× 318 0.6× 386 1.2× 389 1.8× 189 1.3× 81 1.3k
Chikako Shimizu Japan 17 626 0.8× 484 0.9× 157 0.5× 166 0.8× 144 1.0× 53 975
David J. Byrne Australia 20 627 0.8× 342 0.6× 333 1.0× 295 1.3× 233 1.5× 51 1.2k
Yien Ning Sophia Wong United Kingdom 8 687 0.9× 284 0.5× 387 1.2× 350 1.6× 325 2.2× 17 1.1k
Noelia Tarazona Spain 19 584 0.8× 433 0.8× 490 1.5× 383 1.7× 156 1.0× 58 1.3k
Gert Van den Eynden Belgium 17 861 1.1× 381 0.7× 400 1.2× 289 1.3× 445 2.9× 34 1.3k
Nadia Dandachi Austria 23 799 1.1× 508 0.9× 565 1.7× 215 1.0× 61 0.4× 57 1.5k

Countries citing papers authored by Marzia Locatelli

Since Specialization
Citations

This map shows the geographic impact of Marzia Locatelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marzia Locatelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marzia Locatelli more than expected).

Fields of papers citing papers by Marzia Locatelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marzia Locatelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marzia Locatelli. The network helps show where Marzia Locatelli may publish in the future.

Co-authorship network of co-authors of Marzia Locatelli

This figure shows the co-authorship network connecting the top 25 collaborators of Marzia Locatelli. A scholar is included among the top collaborators of Marzia Locatelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marzia Locatelli. Marzia Locatelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conforti, Fabio, Laura Pala, Tommaso De Pas, et al.. (2025). Why Adjuvant Treatment With a CDK4/6 Inhibitor Should Be Recommended for Women With High-Risk Breast Cancer: Methodologic Considerations on Available Evidence. Journal of Clinical Oncology. 43(30). 3237–3244.
2.
Conforti, Fabio, Laura Pala, Diletta Di Mitri, et al.. (2025). Sex hormones, the anticancer immune response, and therapeutic opportunities. Cancer Cell. 43(3). 343–360. 14 indexed citations
3.
Aliaga, Pamela Trillo, Dario Trapani, José Luís Sandoval, et al.. (2021). Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials. Cancers. 13(22). 5829–5829. 10 indexed citations
4.
Tarantino, Paolo, Antonio Marra, Sara Gandini, et al.. (2020). Association between baseline tumour burden and outcome in patients with cancer treated with next-generation immunoncology agents. European Journal of Cancer. 139. 92–98. 15 indexed citations
5.
Duso, Bruno A., Dario Trapani, Giulia Viale, et al.. (2018). Clinical efficacy of ribociclib as a first-line therapy for HR-positive, advanced breast cancer. Expert Opinion on Pharmacotherapy. 19(3). 299–305. 4 indexed citations
6.
Locatelli, Marzia & Giuseppe Curigliano. (2017). Notch inhibitors and their role in the treatment of triple negative breast cancer: promises and failures. Current Opinion in Oncology. 29(6). 411–427. 28 indexed citations
7.
Aurilio, Gaetano, Vincenzo Bagnardi, Franco Nolè, et al.. (2015). Outcome of Immediate Breast Reconstruction in Patients With Nonendocrine-Responsive Breast Cancer: A Monoinstitutional Case-Control Study. Clinical Breast Cancer. 15(5). e237–e241. 13 indexed citations
8.
Espósito, Angela, Carmen Criscitiello, Marzia Locatelli, Monica Milano, & Giuseppe Curigliano. (2015). Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies. Pharmacology & Therapeutics. 157. 120–124. 84 indexed citations
9.
Espósito, Angela, Carmen Criscitiello, Lucia Gelao, et al.. (2015). Mechanisms of anorexia–cachexia syndrome and rational for treatment with selective ghrelin receptor agonist. Cancer Treatment Reviews. 41(9). 793–797. 26 indexed citations
10.
Aurilio, Gaetano, Vincenzo Bagnardi, Rossella Graffeo, et al.. (2014). Does immediate breast reconstruction after mastectomy and neoadjuvant chemotherapy influence the outcome of patients with non-endocrine responsive breast cancer?. PubMed. 34(11). 6677–83. 15 indexed citations
11.
Criscitiello, Carmen, Angela Espósito, Lucia Gelao, et al.. (2014). Immune approaches to the treatment of breast cancer, around the corner?. Breast Cancer Research. 16(1). 204–204. 37 indexed citations
12.
Criscitiello, Carmen, Fabrice André, Alastair M. Thompson, et al.. (2014). Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives. Breast Cancer Research. 16(2). 205–205. 58 indexed citations
13.
Locatelli, Marzia, Carmen Criscitiello, Angela Espósito, et al.. (2014). QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive review. Targeted Oncology. 10(1). 27–43. 14 indexed citations
14.
Criscitiello, Carmen, Davide Disalvatore, Michelino De Laurentiis, et al.. (2013). High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer. The Breast. 23(1). 69–75. 84 indexed citations
15.
Kneubil, Maximiliano Cassilha, Edoardo Botteri, Nicole Rotmensz, et al.. (2013). Locoregional recurrence in patients with HER2 positive breast cancer. The Breast. 22(5). 856–862. 10 indexed citations
16.
Curigliano, Giuseppe, Carmen Criscitiello, Angela Espósito, et al.. (2013). Best management of locally advanced inoperable breast cancer. European Journal of Cancer Supplements. 11(2). 289–290. 5 indexed citations
17.
Espósito, Angela, Alberto Bardelli, Carmen Criscitiello, et al.. (2013). Monitoring tumor-derived cell-free DNA in patients with solid tumors: Clinical perspectives and research opportunities. Cancer Treatment Reviews. 40(5). 648–655. 91 indexed citations
18.
Curigliano, Giuseppe, Carmen Criscitiello, Angela Espósito, et al.. (2013). Developing an effective breast cancer vaccine: Challenges to achieving sterile immunity versus resetting equilibrium. The Breast. 22. S96–S99. 7 indexed citations
19.
Curigliano, Giuseppe, Davide Disalvatore, Carmen Criscitiello, et al.. (2012). Adjuvant trastuzumab in elderly with HER-2 positive breast cancer: A systematic review of randomized controlled trials. Cancer Treatment Reviews. 39(1). 44–50. 57 indexed citations
20.
Curigliano, Giuseppe, Marzia Locatelli, Luca Fumagalli, et al.. (2012). Targeting the subtypes of breast cancer: rethinking investigational drugs. Expert Opinion on Investigational Drugs. 21(2). 191–204. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiayi Wu Breakdown of academic impact, for papers by Yoshiya Horimoto Breakdown of academic impact, for papers by Weikai Xiao Breakdown of academic impact, for papers by Maria Martinez‐García Breakdown of academic impact, for papers by Chikako Shimizu Breakdown of academic impact, for papers by David J. Byrne Breakdown of academic impact, for papers by Yien Ning Sophia Wong Breakdown of academic impact, for papers by Noelia Tarazona Breakdown of academic impact, for papers by Gert Van den Eynden Breakdown of academic impact, for papers by Nadia Dandachi
Rankless by CCL
2026